Liposomes, marvels in biopharmaceutics, are microscopic vesicles composed of lipid bilayers. These versatile structures hold immense promise in drug delivery, encapsulating pharmaceutical agents within their lipid layers. The liposome's unique ability to mimic cell membranes enables targeted drug delivery, enhancing therapeutic efficacy while minimizing side effects.
In the realm of biopharmaceutics, liposomes serve as ingenious carriers for both hydrophobic and hydrophilic drugs, offering a controlled and sustained release. Their biocompatibility and customizable surface properties facilitate interaction with specific cell types, allowing for precision in therapeutic interventions. This has profound implications for treating various diseases, including cancer, infections, and inflammatory disorders.
The flexibility of liposomes extends to their adaptability for incorporating imaging agents, making them invaluable tools in diagnostics. As biopharmaceutics continues to evolve, liposomes stand at the forefront, ushering in a new era of targeted and personalized medicine, poised to revolutionize the landscape of drug delivery and therapeutic interventions.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India